Prevention of clinically important deteriorations in COPD with umeclidinium/vilanterol
Prevention of clinically important deteriorations in COPD with umeclidinium/vilanterol
About this item
Full title
Author / Creator
Publisher
New Zealand: Dove Medical Press Limited
Journal title
Language
English
Formats
Publication information
Publisher
New Zealand: Dove Medical Press Limited
Subjects
More information
Scope and Contents
Contents
Minimizing the risk of disease progression and exacerbations is the key goal of COPD management, as these are well-established indicators of poor COPD prognosis. We developed a novel composite end point assessing three important aspects (lung function, health status, and exacerbations) of worsening in COPD. The objective was to determine whether du...
Alternative Titles
Full title
Prevention of clinically important deteriorations in COPD with umeclidinium/vilanterol
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4928660
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4928660
Other Identifiers
ISSN
1178-2005,1176-9106
E-ISSN
1178-2005
DOI
10.2147/COPD.S101612
